215 related articles for article (PubMed ID: 8993549)
1. The peroxisome proliferator-activated receptors: ligands and activators.
Forman BM; Chen J; Evans RM
Ann N Y Acad Sci; 1996 Dec; 804():266-75. PubMed ID: 8993549
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism.
Latruffe N; Vamecq J
Biochimie; 1997; 79(2-3):81-94. PubMed ID: 9209701
[TBL] [Abstract][Full Text] [Related]
3. Differential activation of peroxisome proliferator-activated receptor-gamma by troglitazone and rosiglitazone.
Camp HS; Li O; Wise SC; Hong YH; Frankowski CL; Shen X; Vanbogelen R; Leff T
Diabetes; 2000 Apr; 49(4):539-47. PubMed ID: 10871190
[TBL] [Abstract][Full Text] [Related]
4. Discovery of ligands for the nuclear peroxisome proliferator-activated receptors.
Willson TM; Lehmann JM; Kliewer SA
Ann N Y Acad Sci; 1996 Dec; 804():276-83. PubMed ID: 8993550
[TBL] [Abstract][Full Text] [Related]
5. [Peroxisome proliferator-activated receptor(PPAR)--structure, function, tissue distribution, gene expression].
Takeyama K; Kodera Y; Suzawa M; Kato S
Nihon Rinsho; 2000 Feb; 58(2):357-63. PubMed ID: 10707558
[TBL] [Abstract][Full Text] [Related]
6. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation.
Kliewer SA; Lenhard JM; Willson TM; Patel I; Morris DC; Lehmann JM
Cell; 1995 Dec; 83(5):813-9. PubMed ID: 8521498
[TBL] [Abstract][Full Text] [Related]
7. Regulation of macrophage gene expression by peroxisome-proliferator-activated receptor gamma: implications for cardiovascular disease.
Tontonoz P; Nagy L
Curr Opin Lipidol; 1999 Dec; 10(6):485-90. PubMed ID: 10680041
[TBL] [Abstract][Full Text] [Related]
8. Regulation of triglyceride metabolism by PPARs: fibrates and thiazolidinediones have distinct effects.
Auwerx J; Schoonjans K; Fruchart JC; Staels B
J Atheroscler Thromb; 1996; 3(2):81-9. PubMed ID: 9226459
[TBL] [Abstract][Full Text] [Related]
9. Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-gamma.
Wang M; Wise SC; Leff T; Su TZ
Diabetes; 1999 Feb; 48(2):254-60. PubMed ID: 10334298
[TBL] [Abstract][Full Text] [Related]
10. Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass.
Gavrilova O; Haluzik M; Matsusue K; Cutson JJ; Johnson L; Dietz KR; Nicol CJ; Vinson C; Gonzalez FJ; Reitman ML
J Biol Chem; 2003 Sep; 278(36):34268-76. PubMed ID: 12805374
[TBL] [Abstract][Full Text] [Related]
11. A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor-alpha (PPAR-alpha) and PPAR-gamma: effect of PPAR-alpha activation on abnormal lipid metabolism in liver of Zucker fatty rats.
Murakami K; Tobe K; Ide T; Mochizuki T; Ohashi M; Akanuma Y; Yazaki Y; Kadowaki T
Diabetes; 1998 Dec; 47(12):1841-7. PubMed ID: 9836514
[TBL] [Abstract][Full Text] [Related]
12. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma).
Lehmann JM; Moore LB; Smith-Oliver TA; Wilkison WO; Willson TM; Kliewer SA
J Biol Chem; 1995 Jun; 270(22):12953-6. PubMed ID: 7768881
[TBL] [Abstract][Full Text] [Related]
13. The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses.
Clark RB; Bishop-Bailey D; Estrada-Hernandez T; Hla T; Puddington L; Padula SJ
J Immunol; 2000 Feb; 164(3):1364-71. PubMed ID: 10640751
[TBL] [Abstract][Full Text] [Related]
14. The effects of fibrates and thiazolidinediones on plasma triglyceride metabolism are mediated by distinct peroxisome proliferator activated receptors (PPARs).
Staels B; Schoonjans K; Fruchart JC; Auwerx J
Biochimie; 1997; 79(2-3):95-9. PubMed ID: 9209702
[TBL] [Abstract][Full Text] [Related]
15. Trans-differentiation of myoblasts to adipoblasts: triggering effects of fatty acids and thiazolidinediones.
Grimaldi PA; Teboul L; Inadera H; Gaillard D; Amri EZ
Prostaglandins Leukot Essent Fatty Acids; 1997 Jul; 57(1):71-5. PubMed ID: 9250611
[TBL] [Abstract][Full Text] [Related]
16. Adipocyte differentiation is regulated by a prostaglandin liganded to the nuclear peroxisome proliferator-activated receptor.
Wolf G
Nutr Rev; 1996 Sep; 54(9):290-2. PubMed ID: 9009672
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor gamma inhibits the migration of dendritic cells: consequences for the immune response.
Angeli V; Hammad H; Staels B; Capron M; Lambrecht BN; Trottein F
J Immunol; 2003 May; 170(10):5295-301. PubMed ID: 12734379
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of proliferation and estrogen receptor signaling by peroxisome proliferator-activated receptor gamma ligands in uterine leiomyoma.
Houston KD; Copland JA; Broaddus RR; Gottardis MM; Fischer SM; Walker CL
Cancer Res; 2003 Mar; 63(6):1221-7. PubMed ID: 12649180
[TBL] [Abstract][Full Text] [Related]
19. Novel insulin sensitizers: pharmacogenomic aspects.
Otto C; Lehrke M; Göke B
Pharmacogenomics; 2002 Jan; 3(1):99-116. PubMed ID: 11966407
[TBL] [Abstract][Full Text] [Related]
20. Regulation of cytokine expression by ligands of peroxisome proliferator activated receptors.
Cunard R; Ricote M; DiCampli D; Archer DC; Kahn DA; Glass CK; Kelly CJ
J Immunol; 2002 Mar; 168(6):2795-802. PubMed ID: 11884448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
